Javelin rockets as drug stocks head south

Investor jitters over the state of the Chinese economy weigh on both the broader market and drug sector in early action.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.